Dabbous, H. M., El-Sayed, M. H., Assal, G. E., Elghazaly, H., Ebeid, F. F. S., Sherief, A. F., . . . TagelDin, M. A. (2021). Safety and efficacy of favipiravir versus hydroxychloroquine in management of COVID-19: A randomised controlled trial. Nature Portfolio.
Cita Chicago Style (17a ed.)Dabbous, Hany M., et al. Safety and Efficacy of Favipiravir Versus Hydroxychloroquine in Management of COVID-19: A Randomised Controlled Trial. Nature Portfolio, 2021.
Cita MLA (8a ed.)Dabbous, Hany M., et al. Safety and Efficacy of Favipiravir Versus Hydroxychloroquine in Management of COVID-19: A Randomised Controlled Trial. Nature Portfolio, 2021.
Precaución: Estas citas no son 100% exactas.